Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion

NCT01262612 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01262612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01262612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2010
Completion date
Not reported
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant ascites, malignant pleural effusion